Zars Topical Anesthetic Peel Approved For Dermatological Procedures
This article was originally published in The Pink Sheet Daily
The lidocaine/tetracaine topical anesthetic joins Zars’ Synera combo patch, launched in June by marketing partner Endo.
You may also be interested in...
CEO stepping down and no R&D leader on board, as officials evaluate pipeline.
Commercialization of the fixed-dose combo buys lifecycle management for Forest and should support future drug development for partner Adamas, the originator of the technology behind the combination.